STAGE IVC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Clinical trials for STAGE IVC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IVC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to extend life in advanced head and neck cancer
Disease control OngoingThis study tested whether adding the drug bevacizumab to standard chemotherapy helps people with head and neck cancer that has returned or spread live longer. About 400 adults with this advanced cancer took part. The goal was to see if the combination improves overall survival co…
Matched conditions: STAGE IVC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo shows promise for tough head and neck cancers
Disease control OngoingThis study tests whether combining two drugs, pembrolizumab and cabozantinib, can shrink tumors in people with head and neck cancer that has returned or spread and cannot be removed by surgery. The trial includes 36 adults with certain types of head and neck squamous cell carcino…
Matched conditions: STAGE IVC OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC